People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tychon Biosciences LLC | — | Biotech / Pharma | Pre-Seed | $671K | $10.2M | 2018 |
Arek Z. Dudek, MD PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Arek Z. Dudek, MD PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Danny J. Cunagin | 1 | 10 |
| Troy D. Kopischke | 1 | 10 |
| Mark D. Sylvester | 1 | 1 |
| Charles J. Muscoplat, PhD | 1 | 1 |
| Mark Z. Sylvester | 1 | 1 |
| John Z. MacDonald, PhD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.